Research Summary
Low-Pressure HBOT for Blast-Induced Post-Concussion Syndrome and PTSD
Read the full study
This is a plain-language summary. The full study is published by the Journal of Neurotrauma and is not ours to reproduce, but you can read the complete original directly from the publisher: Read the Full Study at doi.org/10.1089/neu.2011.1895 →
This 2012 study, led by Dr. Paul Harch and colleagues at Louisiana State University, is one of the more frequently cited pieces of research behind low-pressure HBOT for brain injury. It examined sixteen military service members with chronic post-concussion syndrome caused by blast exposure in Iraq or Afghanistan — most of whom also carried a PTSD diagnosis, and had been living with symptoms for years.
What the researchers did
Each participant received forty one-hour hyperbaric sessions at 1.5 ATA — a mild pressure, comparable to what's used in outpatient soft-shell chambers — over about a month. Before and after treatment, the team ran a battery of neuropsychological testing, brain blood-flow imaging (SPECT), and standard symptom questionnaires for PTSD, depression, and concussion symptoms.
What they found
The changes were substantial. Full-scale IQ rose by an average of nearly 15 points. Working memory and attention scores improved significantly. PTSD symptom scores dropped by roughly 30%, and depression and anxiety scores fell as well. On brain imaging, the majority of subjects showed measurably improved blood flow to the brain, including in the hippocampus — a region tied closely to memory. Most participants also reported meaningful relief from headaches, sleep disruption, and cognitive symptoms, and many were able to reduce or stop psychiatric or pain medications they'd been taking before treatment.
Side effects were generally mild — some reversible ear discomfort, and a temporary worsening of symptoms partway through treatment in a few subjects that resolved with continued sessions. The authors found no evidence of oxygen toxicity at this pressure and treatment schedule.
Why it matters
What makes this study notable is the pressure used: 1.5 ATA is well below the 2.0+ ATA typically associated with hospital-based, FDA-approved hyperbaric protocols. The results here support the idea that meaningful neurological improvement doesn't require high pressure — a mild, outpatient-accessible protocol produced measurable, significant change on both symptom scales and objective brain imaging.
As with any single study, this one has real limits worth naming honestly: a small sample of sixteen subjects, no placebo control group, and unblinded assessment of symptoms (though the SPECT imaging analysis was independently and, in part, blindly reviewed). The authors themselves call it a preliminary report and note that larger, more rigorously controlled studies are still needed. It's a genuinely encouraging data point, not a final word.
Let's Talk
You don't need a diagnosis in hand to reach out.
We're happy to walk through the science, the evidence, and what to expect. Tell us a little about your situation and we'll take it from there — no pressure, no obligation.